220 related articles for article (PubMed ID: 32622510)
1. Autoimmune and demyelinating optic neuritis.
García Ortega A; Montañez Campos FJ; Muñoz S; Sanchez-Dalmau B
Arch Soc Esp Oftalmol (Engl Ed); 2020 Aug; 95(8):386-395. PubMed ID: 32622510
[TBL] [Abstract][Full Text] [Related]
2. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
[TBL] [Abstract][Full Text] [Related]
3. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.
Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D
Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238
[TBL] [Abstract][Full Text] [Related]
4. MRI Characteristics of NMO, MOG and MS Related Optic Neuritis.
Winter A; Chwalisz B
Semin Ophthalmol; 2020 Nov; 35(7-8):333-342. PubMed ID: 33395326
[TBL] [Abstract][Full Text] [Related]
5. Clinical and MRI phenotype of children with MOG antibodies.
Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
[TBL] [Abstract][Full Text] [Related]
6. [Anti-MOG antibody in different types of immune-mediated optic neuritis].
Kong XY; Peng JT; Liu LJ; Yan R; Zhang XJ
Zhonghua Yan Ke Za Zhi; 2012 Dec; 48(12):1069-72. PubMed ID: 23336409
[TBL] [Abstract][Full Text] [Related]
7. Antibody Testing in Atypical Optic Neuritis.
Truong-Le M; Chwalisz B
Semin Ophthalmol; 2020 Aug; 35(5-6):287-295. PubMed ID: 33150802
[TBL] [Abstract][Full Text] [Related]
8. Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients.
Deschamps R; Lecler A; Lamirel C; Aboab J; Gueguen A; Bensa C; Vignal C; Gout O
Eur J Neurol; 2017 Jun; 24(6):875-879. PubMed ID: 28477397
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.
Petzold A; Woodhall M; Khaleeli Z; Tobin WO; Pittock SJ; Weinshenker BG; Vincent A; Waters P; Plant GT
J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1021-1026. PubMed ID: 31118222
[TBL] [Abstract][Full Text] [Related]
10. Update on Pediatric Optic Neuritis.
Gise RA; Heidary G
Curr Neurol Neurosci Rep; 2020 Mar; 20(3):4. PubMed ID: 32124097
[TBL] [Abstract][Full Text] [Related]
11. Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
Ambika S; Balasubramanian M; Theresa L; Veeraputhiran A; Arjundas D
Int Ophthalmol; 2015 Dec; 35(6):801-6. PubMed ID: 25682013
[TBL] [Abstract][Full Text] [Related]
12. Clinical and radiologic approach to 'typical' versus antibody-related optic neuritis.
Caron-Cantin M; Cestari DM; Fortin E
Curr Opin Ophthalmol; 2019 Nov; 30(6):412-417. PubMed ID: 31503075
[TBL] [Abstract][Full Text] [Related]
13. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.
Nakamura M; Iwasaki Y; Takahashi T; Kaneko K; Nakashima I; Kunieda T; Kaneko S; Kusaka H
Mult Scler Relat Disord; 2017 Oct; 17():148-150. PubMed ID: 29055448
[TBL] [Abstract][Full Text] [Related]
14. Optic neuritis in the era of biomarkers.
Chen JJ; Pittock SJ; Flanagan EP; Lennon VA; Bhatti MT
Surv Ophthalmol; 2020; 65(1):12-17. PubMed ID: 31425702
[TBL] [Abstract][Full Text] [Related]
15. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
Chen JJ; Bhatti MT
Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
[TBL] [Abstract][Full Text] [Related]
16. Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity.
Waschbisch A; Atiya M; Schaub C; Derfuss T; Schwab S; Lee DH; Müller M; Linker RA
J Neurol Sci; 2013 Aug; 331(1-2):72-5. PubMed ID: 23735776
[TBL] [Abstract][Full Text] [Related]
17. [Optic neuropathy in positive anti-MOG antibody syndrome].
Merabtene L; Vignal Clermont C; Deschamps R
J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
[TBL] [Abstract][Full Text] [Related]
18. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
Ramanathan S; Prelog K; Barnes EH; Tantsis EM; Reddel SW; Henderson AP; Vucic S; Gorman MP; Benson LA; Alper G; Riney CJ; Barnett M; Parratt JD; Hardy TA; Leventer RJ; Merheb V; Nosadini M; Fung VS; Brilot F; Dale RC
Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
[TBL] [Abstract][Full Text] [Related]
19. Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.
Oliveira LM; Apóstolos-Pereira SL; Pitombeira MS; Bruel Torretta PH; Callegaro D; Sato DK
Mult Scler; 2019 Dec; 25(14):1907-1914. PubMed ID: 30417715
[TBL] [Abstract][Full Text] [Related]
20. [Typical and atypical optic neuritis].
Sheremet NL; Eliseeva DD; Kalashnikova AK; Zakharova MN
Vestn Oftalmol; 2023; 139(6):175-182. PubMed ID: 38235645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
